STAT3 and idiopathic pulmonary fibrosis: As shown by immunoblotting, LBH589 as well as pirfenidone-treatment resulted in significant reduction of profibrotic STAT3-phosphorylation in primary IPF-fibroblasts, when compared to vehicle-treated cells (Fig 7A).